BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 25493912)

  • 1. First-in-man radial access renal denervation with the ReCor Radiance™ catheter.
    Daemen J; Van Mieghem N
    EuroIntervention; 2015 Feb; 10(10):1209-12. PubMed ID: 25493912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twelve-month results of the rapid renal sympathetic denervation for resistant hypertension using the OneShotTM ablation system (RAPID) study.
    Verheye S; Ormiston J; Bergmann MW; Sievert H; Schwindt A; Werner N; Vogel B; Colombo A
    EuroIntervention; 2015 Feb; 10(10):1221-9. PubMed ID: 25452198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First report of transradial renal denervation with the dedicated radiofrequency Iberis™ catheter.
    Honton B; Pathak A; Sauguet A; Fajadet J
    EuroIntervention; 2014; 9(12):1385-8. PubMed ID: 24161437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal denervation with a percutaneous bipolar radiofrequency balloon catheter in patients with resistant hypertension: 6-month results from the REDUCE-HTN clinical study.
    Sievert H; Schofer J; Ormiston J; Hoppe UC; Meredith IT; Walters DL; Azizi M; Diaz-Cartelle J; Cohen-Mazor M
    EuroIntervention; 2015 Feb; 10(10):1213-20. PubMed ID: 25452197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled circumferential renal sympathetic denervation with preservation of the renal arterial wall using intraluminal ultrasound: a next-generation approach for treating sympathetic overactivity.
    Sakakura K; Roth A; Ladich E; Shen K; Coleman L; Joner M; Virmani R
    EuroIntervention; 2015 Feb; 10(10):1230-8. PubMed ID: 25349043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and performance of the second generation EnligHTN™ Renal Denervation System in patients with drug-resistant, uncontrolled hypertension.
    Worthley SG; Wilkins GT; Webster MW; Montarello JK; Delacroix S; Whitbourn RJ; Warren RJ
    Atherosclerosis; 2017 Jul; 262():94-100. PubMed ID: 28531827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transradial renal denervation for the treatment of resistant hypertension.
    Dong H; Jiang X; Liang T; Zou Y; Guan T; Peng M; Song L; Zhang H; Wu H; Xu B; Yang Y; Gao R
    J Invasive Cardiol; 2014 Jul; 26(7):322-7. PubMed ID: 24993989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.
    Prochnau D; Lucas N; Kuehnert H; Figulla HR; Surber R
    EuroIntervention; 2012 Jan; 7(9):1077-80. PubMed ID: 21959556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Renal denervation by trans-radial access for resistant hypertension].
    Garcia-Alonso C; Unterseeh T; Garot P; Louvard Y; Lefevre T; Morice MC; Benamer H; ; ;
    Ann Cardiol Angeiol (Paris); 2014 Dec; 63(6):460-4. PubMed ID: 25450996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood Pressure Response to Main Renal Artery and Combined Main Renal Artery Plus Branch Renal Denervation in Patients With Resistant Hypertension.
    Fengler K; Ewen S; Höllriegel R; Rommel KP; Kulenthiran S; Lauder L; Cremers B; Schuler G; Linke A; Böhm M; Mahfoud F; Lurz P
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Renal denervation a treatment for resistant hypertension: a French experience].
    Benamer H; Mylotte D; Garcia-Alonso C; Unterseeh T; Garot P; Louvard Y; Lefevre T; Morice MC;
    Ann Cardiol Angeiol (Paris); 2013 Dec; 62(6):384-91. PubMed ID: 24182849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catheter-based renal denervation for treatment of resistant hypertension.
    Vase H; Mathiassen ON; Kaltoft A; Pedersen EB; Christensen KL; Buus NH; Lederballe O; Lassen JF; Bøtker HE; Thuesen L
    Dan Med J; 2012 Jun; 59(6):A4439. PubMed ID: 22677237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial.
    Worthley SG; Tsioufis CP; Worthley MI; Sinhal A; Chew DP; Meredith IT; Malaiapan Y; Papademetriou V
    Eur Heart J; 2013 Jul; 34(28):2132-40. PubMed ID: 23782649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of the ALSTER BP real-world registry on renal denervation employing the Symplicity system.
    Kaiser L; Beister T; Wiese A; von Wedel J; Meincke F; Kreidel F; Busjahn A; Kuck KH; Bergmann MW
    EuroIntervention; 2014 May; 10(1):157-65. PubMed ID: 24472799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-in-human use of the OneShot™ renal denervation system from Covidien.
    Ormiston JA; Watson T; van Pelt N; Stewart R; Haworth P; Stewart JT; Webster MW
    EuroIntervention; 2013 Jan; 8(9):1090-4. PubMed ID: 23339814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next generation renal denervation: chemical "perivascular" renal denervation with alcohol using a novel drug infusion catheter.
    Fischell TA; Fischell DR; Ghazarossian VE; Vega F; Ebner A
    Cardiovasc Revasc Med; 2015 Jun; 16(4):221-7. PubMed ID: 25979565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal denervation for resistant hypertension: acute results and long-term follow-up.
    Korovesis S; Giazitzoglou E; Pantos I; Tzanalaridou E; Kokladi M; Venetsanakos I; Paxinos G; Katritsis DG
    Hellenic J Cardiol; 2014; 55(3):211-6. PubMed ID: 24862613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mid-Term Vascular Safety of Renal Denervation Assessed by Follow-up MR Imaging.
    Schmid A; Schmieder R; Lell M; Janka R; Veelken R; Schmieder RE; Uder M; Ott C
    Cardiovasc Intervent Radiol; 2016 Mar; 39(3):426-32. PubMed ID: 26253780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial.
    Azizi M; Schmieder RE; Mahfoud F; Weber MA; Daemen J; Davies J; Basile J; Kirtane AJ; Wang Y; Lobo MD; Saxena M; Feyz L; Rader F; Lurz P; Sayer J; Sapoval M; Levy T; Sanghvi K; Abraham J; Sharp ASP; Fisher NDL; Bloch MJ; Reeve-Stoffer H; Coleman L; Mullin C; Mauri L;
    Lancet; 2018 Jun; 391(10137):2335-2345. PubMed ID: 29803590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal denervation therapy for the treatment of resistant hypertension: a position statement by the Canadian Hypertension Education Program.
    Khan NA; Herman RJ; Quinn RR; Rabkin SW; Ravani P; Tobe SW; Feldman RD; Wijeysundera HC; Padwal RS;
    Can J Cardiol; 2014 Jan; 30(1):16-21. PubMed ID: 24269056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.